Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | STON2 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
mRNA | NBPF9 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
mRNA | PERP | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0003 |
mRNA | DNAJC14 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
mRNA | COL6A3 | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
mRNA | SUMF2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
mRNA | BSPRY | CCLE | pan-cancer | AAC | 0.2 | 0.0004 |
mRNA | EIF1AX | CCLE | pan-cancer | AAC | -0.17 | 0.0004 |
mRNA | OR51A4 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
mRNA | SPTLC1 | FIMM | pan-cancer | AAC | 0.61 | 0.0004 |